Neue Therapieoption bei Diabetes mellitus Typ 2: EMPA-REG-Studie
Standard
Neue Therapieoption bei Diabetes mellitus Typ 2: EMPA-REG-Studie. / Windler, E; Nitschmann, S.
In: INTERNIST, Vol. 57, No. 1, 01.2016, p. 102-103.Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Neue Therapieoption bei Diabetes mellitus Typ 2: EMPA-REG-Studie
AU - Windler, E
AU - Nitschmann, S
N1 - Editorial Material
PY - 2016/1
Y1 - 2016/1
KW - Diabetes Mellitus, Type 1/drug therapy
KW - Diabetes Mellitus, Type 2/drug therapy
KW - Humans
KW - Hypoglycemic Agents/therapeutic use
U2 - 10.1007/s00108-015-3848-z
DO - 10.1007/s00108-015-3848-z
M3 - Andere (Vorworte u.ä.)
C2 - 26634255
VL - 57
SP - 102
EP - 103
JO - INTERNIST
JF - INTERNIST
SN - 0020-9554
IS - 1
ER -